Thalassemia secondary prevention

Thalassemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thalassemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Thalassemia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Thalassemia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thalassemia secondary prevention
CDC on Thalassemia secondary prevention
Thalassemia secondary prevention in the news
Blogs on Thalassemia secondary prevention
Directions to Hospitals Treating Thalassemia
Risk calculators and risk factors for Thalassemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]

Overview

There is some role for genetic counseling and education as a means of secondary prevention of thalassemia.

Secondary Prevention

Secondary prevention for thalassemia focuses on preventing the birth of infants who could be at risk for thalassemia. Secondary prevention involves genetic counseling of patients who are known carriers of alpha-globin or beta-globin chain mutations. Education programs have been instituted in a variety of countries to address secondary prevention.